The Infant Ventilator Market is expected to grow at a 7.5 % CAGR during the forecast period for 2023-2031.
A ventilator is a medical device that exchanges oxygen and carbon dioxide for mechanical assistance. It's widespread in medical settings. This technique is also known as artificial respiration. It is a device that lets breathable air enter and exit the lungs, allowing people who are physically unable to breathe or who are breathing insufficiently to receive breathing assistance. Neonatal ventilators are ventilators explicitly designed for newborns. The rise in neonatal death rates is expected to fuel the growth of the neonatal ventilators market during the projected period. Moreover, the market for neonatal ventilators is predicted to grow as the number of preterm babies with respiratory issues rises. Additionally, technological advancements in neonatal ventilators are projected to slow the market's growth. Furthermore, rising public awareness regarding the treatment of chronic respiratory illnesses, as well as increased private investment by key market players, has resulted in the widespread use of neonatal ventilators, boosting market growth even further.
However, the rising cost of neonatal ventilators, on the other hand, is likely to hinder market growth throughout the forecast period. Furthermore, the expensive cost of ventilators is expected to restrict their global adoption. The high-cost constraint significantly impacts noninvasive ventilators, which are more effective than invasive ventilators. In addition, in low-income countries, a lack of experienced practitioners, suitable healthcare facilities, and healthcare financing will hinder the smooth implementation of infant ventilators.
The Infant Ventilator market is segmented on the basis of product, ventilation mode, and application. Based on product, the market is segmented as Mechanical, Electronic, Pneumatic, and Electro-pneumatic. By Ventilation Mode, the market is segmented into Invasive and Non-invasive. By application, the market is segmented into Resuscitation, Emergency, Transport, Clinical, and Other (COPD, homecare, etc.).
Invasive ventilators are not moveable and are usually utilized in hospitals and intensive care units. The invasive segment currently dominates the worldwide neonatal ventilator market in 2021 and is expected to do so throughout the projected period. On the other hand, noninvasive newborn ventilators are portable and can be used in hospitals and at home. However, the noninvasive ventilation market is predicted to develop at the fastest CAGR throughout the forecast period because of its cost-effectiveness, higher tolerance, and convenience compared to invasive ventilation, as well as easier availability outside ICU settings.
The home care segment is predicted to develop at the quickest rate during the projection period. The industry is growing as a result of an increasing number of government initiatives aimed at reducing healthcare costs by boosting home healthcare. Another important aspect driving market expansion is value-based healthcare. Medicare reimbursements in the United States are very beneficial when it comes to offering value-based healthcare for better patient outcomes at a reasonable cost. As a result, in-home care has become a popular treatment option, and it is predicted to rise at a healthy rate over the forecast period.
North America dominates the neonatal ventilators market because of increased awareness and rising government spending in the healthcare business. Furthermore, the increased use of improved newborn ventilation technology for emergency and routine use and the growing need for advanced healthcare facilities will propel the neonatal ventilators market in the area to new heights over the forecast period. However, the market in the Asia Pacific is also expected to increase significantly throughout the projected period, owing to rising healthcare expenditure, different collaborations, new product launches, and strategic agreements undertaken by local companies during the pandemic.
| Report Attribute | Specifications |
| Growth rate CAGR | CAGR of 7.5 % from 2023 to 2031 |
| Quantitative units | Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments covered | By Product, By Ventilation Mode, By Application |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | ACUTRONIC Medical Systems, Airon Corporation, Atlantamed, Atom Medical Corporation, Allied Healthcare Products, Inc., AVI Healthcare, Bio-Med Devices, Breas Medical AB, Comen, Drägerwerk AG & Co. KGaA, Fanem Ltda, Fisher & Paykel Healthcare, Fritz Stephan, GINEVRI srl, Hamilton Medical, Heinen und Löwenstein, HERSILL, HEYER Medical, Leistung, Magnamed, Mediprema, Medtronic, Mindray, MS Westfalia, Neotech Medical Systems, Neumovent, NOVOS, O-Two Medical Technologies, Okuman Medikal Sistemler Anonim Sirketi, Paramed International, Phoenix Medical Systems, Progetti S.r.l., Sechrist Industries, Shenzhen Prunus Medical, Shvabe-Zurich, Siare, SLE, Tecme, WILAmed, Hamilton Medical AG, Koninklijke Philips N.V., Löwenstein Medical GmbH & Co. KG, MAQUET Holding B.V. & Co. KG., Nihon Kohden Corp., ResMed, Inc., Soma Technology, Inc., Smiths Group PLC., Utah Medical Products, Inc. Vyaire Medical, Inc., and Vygon SA |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
By Product-
By Ventilation Mode
By Application-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.